Results 181 to 190 of about 10,162 (193)

Interventions for the treatment of decreased bone mineral density associated with HIV infection

The Cochrane Library, 2007

exaly  

Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents

Psychoneuroendocrinology, 2003
Anne Klibanski, D C Goff
exaly  

Does hysterectomy with ovarian conservation affect bone metabolism and density?

Journal of Bone and Mineral Metabolism, 2003
Sulin Cheng, Heinonen A, Harri Sievänen   +2 more
exaly  

Change of bone mineral density and treatment of ankylosing spondylitis. Comment to the article of Kang KY et al. “The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis” Joint Bone Spine 2011;78:188–93

Joint Bone Spine, 2012
Daniel Wendling, Eric Toussirot, Gilles Dumoulin   +2 more
exaly  

Additive effects of antiresorptive agents and exercise on lumbar spine bone mineral density in adults with low bone mass: a meta-analysis

Osteoporosis International, 2014
Gao R, Yuan W
exaly  

Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density

New England Journal of Medicine, 2002
Ian Reid, Jean Kaufman, Jean-Pierre Devogelaer   +2 more
exaly  

An OA phenotype may obtain major benefit from bone-acting agents

Seminars in Arthritis and Rheumatism, 2014
R Largo, Herrero-Beaumont G, Willem Lems   +2 more
exaly  

[New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].

Nihon rinsho. Japanese journal of clinical medicine, 2008
openaire   +1 more source

Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART

Infectious Diseases, 2015
Jean Sibilia, Rose-Marie Javier, David Rey   +2 more
exaly  

[New bone density conservation agents for osteoporosis under research and development: ED-71].

Nihon rinsho. Japanese journal of clinical medicine, 2008
openaire   +1 more source